NL-OMON52435招募中不适用
The Cohort for patient-reported Outcomes, Imaging and trial inclusion in Metastatic BRAin disease - COIMBRA
niversitair Medisch Centrum Utrecht0 个研究点目标入组 2,000 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age >= 18 years;
- •- Either radiographic and/or histologic proof of metastatic brain disease, or
- •eligible for prophylactic cranial irradiation;
- •- Referred to the Department of Radiotherapy for cranial irradiation.
排除标准
- •- Mental disorder or cognitive dysfunction that hinder the patient*s ability to
- •understand the informed consent procedure and/or study details;
- •- Patients with severe psychiatric disorders;
- •- Inability to understand the Dutch language.
研究者
相似试验
招募中
不适用
PRECIOUS-B studyRheumatoid arthritisJPRN-jRCT1041190125Asai Shuji51
已完成
不适用
A cohort study on patient-reported outcomes (PRO) in patients with lifestyle disease who have used Welby My-KarteThose with a lifestyle disease (diabetes, hypertension, or hyperlipidemia)JPRN-UMIN000039658Diabetes And Lifestyle Center,Tomonaga Clinic675
招募中
不适用
A clinical registry to monitor outcomes of upper limb pathology (PRULO)Rotator Cuff pathologyGlenohumeral OsteoarthritisAdhesive CapsulitisGlenohumeral instabilityElbow osteochondral/soft tissue pathologyShoulder osteochondral/soft tissue pathology (other)Hand/wrist osteochondral/soft tissue pathology (other)Musculoskeletal - OsteoarthritisMusculoskeletal - Other muscular and skeletal disordersSurgery - Other surgeryCarpal Tunnel SyndromeACTRN12619000770167Mr Kevin Eng3,000
招募中
不适用
A clinical registry to monitor outcomes of shoulder and knee pathologyShoulder arthritisShoulder dislocation/recurrent instabilityShoulder rotator cuff pathologyKnee arthritisKnee ACL ruptureMusculoskeletal - OsteoarthritisMusculoskeletal - Other muscular and skeletal disordersSurgery - Other surgeryHip OsteoarthritisACTRN12617001161314QEII Jubilee Hospital2,500
尚未招募
不适用
Comparative study of self-report scales in cancer patients undergoing oral antineoplastic medications such as tyrosine kinase inhibitorsAdverse eventsD27.505.954.248RBR-10myxdssniversidade Federal de São Paulo